{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:27:26Z","timestamp":1786728446270,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Versican is a chondroitin sulphate proteoglycan with raised expression at site of inflammation, and uterine fibroids are associated with local inflammation. Hence, this study aimed to estimate serum Versican levels in pre-menopausal women with uterine fibroids to evaluate its diagnostic efficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This case\u2013control study included forty uterine fibroid cases and 40 healthy controls. Cases clinically evaluated with USG findings, that is number, location of fibroid and volume calculated by prolate ellipse formula a \u00d7 b \u00d7 c \u00d7 0.523 (a \u2013 height, b \u2013 width, c \u2013 depth). Biochemical investigations, that is serum Versican levels, were estimated by ELISA with total cholesterol, HDLc and LDLc. Triglycerides by fully automated chemistry analysers. Serum biochemical parameters were compared and correlated with volume of fibroid. Area under receiver operating characteristic curve was calculated along with cut-off value to determine diagnostic potential of Versican, differentiating women with fibroids.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      In the present study, patients with fibroids had decreased levels of serum Versican (79.43 \u00b1 18.60) as compared to healthy controls (101.81 \u00b1 28.24,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). There was a statistically significant negative correlation (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = - 0. 307,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.04) between serum Versican level and volume of fibroid. Area under ROC was 0.726 (95% CI: 0.616-0.836;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). The best cut-off value for serum Versican level was 96.90 ng\/ml with 90% sensitivity and 48% specificity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Serum Versican levels were found significantly lower in women with fibroid with a negative correlation with volume of fibroid uterus. Furthermore, extensive study would help in substantiating diagnostic potential of serum Versican in fibroid uterus patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_320_23","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T13:04:00Z","timestamp":1693227840000},"page":"1704-1709","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Serum versican as a potential biomarker in patients with uterine fibroids: A study from Eastern India"],"prefix":"10.4103","volume":"12","author":[{"given":"Pratima","family":"Jasti","sequence":"first","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PP","family":"Anudeep","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/humrep\/deh146","article-title":"Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells","volume":"19","author":"Yamada","year":"2004","journal-title":"Hum Reprod"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/humupd\/dmx032","article-title":"Extracellular matrix in uterine leiomyoma pathogenesis: A potential target for future therapeutics","volume":"24","author":"Islam","year":"2018","journal-title":"Hum Reprod Update"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0955-0674(02)00375-7","article-title":"Versican: A versatile extracellular matrix proteoglycan in cell biology","volume":"14","author":"Wight","year":"2002","journal-title":"Curr Opin Cell Biol"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"34089","DOI":"10.1074\/jbc.M114.607168","article-title":"A role for versican in the development of leiomyosarcoma","volume":"289","author":"Keire","year":"2014","journal-title":"J Biol Chem"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.3390\/ijms18112435","article-title":"Role of transforming growth factor b in uterine fibroid biology","volume":"18","author":"Ciebiera","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1089\/jwh.2021.0280","article-title":"Uterine Fibroids: Assessing unmet needs from bench to bedside","volume":"30","author":"Aninye","year":"2021","journal-title":"J Womens Health (Larchmt)"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/humupd\/dmv030","article-title":"Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth","volume":"21","author":"Commandeur","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2017.09.004","article-title":"Epidemiology and risk factors of uterine fibroids","volume":"46","author":"Pavone","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/IJWH.S51083","article-title":"Uterine fibroids: Current perspectives","volume":"6","author":"Khan","year":"2014","journal-title":"Int J Womens Health"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0030-1251477","article-title":"New directions in the epidemiology of uterine fibroids","volume":"28","author":"Laughlin","year":"2010","journal-title":"Semin Reprod Med"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1933719115607994","article-title":"Proteoglycans in leiomyoma and normal myometrium: Abundance, steroid hormone control, and implications for pathophysiology","volume":"23","author":"Barker","year":"2016","journal-title":"Reprod Sci"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.109.001289","article-title":"Extracellular matrix molecules: Potential targets in pharmacotherapy","volume":"61","author":"J\u00e4rvel\u00e4inen","year":"2009","journal-title":"Pharmacol Rev"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.matbio.2014.04.003","article-title":"Reprint of: A rapid increase in macrophage-derived versican and hyaluronan in infectious lung disease","volume":"35","author":"Chang","year":"2014","journal-title":"Matrix Biol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1186\/s12889-023-15765-x","article-title":"Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: An age-period-cohort analysis for the global burden of disease 2019 study","volume":"23","author":"Lou","year":"2023","journal-title":"BMC Public Health"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1210\/en.2017-03018","article-title":"Proteomic profiling of human uterine fibroids reveals upregulation of the extracellular matrix protein periostin","volume":"159","author":"Jamaluddin","year":"2018","journal-title":"Endocrinology"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/1933719115607994","article-title":"Proteoglycans in leiomyoma and normal myometrium: Abundance, steroid hormone control, and implications for pathophysiology","volume":"23","author":"Barker","year":"2016","journal-title":"Reprod Sci"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1177\/1933719109343310","article-title":"Transforming growth factor beta3 regulates the versican variants in the extracellular matrix-rich uterine leiomyomas","volume":"16","author":"Norian","year":"2009","journal-title":"Reprod Sci"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/BJ20111996","article-title":"Proteoglycans of uterine fibroids and keloid scars: Similarity in their proteoglycan composition","volume":"443","author":"Carrino","year":"2012","journal-title":"Biochem J"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1210\/jc.2016-3527","article-title":"Versican Proteolysis by ADAMTS proteases and its influence on sex steroid receptor expression in uterine leiomyoma","volume":"102","author":"Gueye","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12931-018-0779-y","article-title":"A Serological biomarker of versican degradation is associated with mortality following acute exacerbations of idiopathic interstitial pneumonia","volume":"19","author":"Sand","year":"2018","journal-title":"Respir Res"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1210\/en.2009-1225","article-title":"Progesterone is essential for maintenance and growth of uterine leiomyoma","volume":"151","author":"Ishikawa","year":"2010","journal-title":"Endocrinology"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"e2312701","DOI":"10.1001\/jamanetworkopen.2023.12701","article-title":"Presence of fibroids on transvaginal ultrasonography in a community-based, diverse cohort of 996 reproductive-age female participants","volume":"6","author":"Huang","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_320_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:08Z","timestamp":1786724828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_320_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_320_23","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"2023-02-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}